Literature DB >> 26791132

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.

Ming Sheng Lim1, Karla Lemmert2, Anoop Enjeti1.   

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive haematological malignancy in the elderly, with a high frequency of cutaneous and bone marrow involvement and poor prognosis. We report a case of BPDCN with classic presentation and discuss its treatment and the value of different investigation tools used in diagnosis and response assessment. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2016        PMID： 26791132      PMCID： PMC4735436          DOI： 10.1136/bcr-2015-214093

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  26 in total

1.  Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.

Authors:  Ashley P Ng; Stephen Lade; Timothy Rutherford; Christopher McCormack; H Miles Prince; David A Westerman
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

2.  Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

Authors:  Arthur E Frankel; Jung H Woo; Chul Ahn; Naveen Pemmaraju; Bruno C Medeiros; Hetty E Carraway; Olga Frankfurt; Stephen J Forman; Xuezhong A Yang; Marina Konopleva; Francine Garnache-Ottou; Fanny Angelot-Delettre; Christopher Brooks; Michael Szarek; Eric Rowinsky
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

3.  Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Tomohiro Aoki; Ritsuro Suzuki; Yachiyo Kuwatsuka; Shinichi Kako; Katsuya Fujimoto; Jun Taguchi; Tadakazu Kondo; Kinya Ohata; Toshiro Ito; Yoshimasa Kamoda; Takahiro Fukuda; Tatsuo Ichinohe; Kengo Takeuchi; Koji Izutsu; Junji Suzumiya
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

4.  Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

Authors:  J Menezes; F Acquadro; M Wiseman; G Gómez-López; R N Salgado; J G Talavera-Casañas; I Buño; J V Cervera; S Montes-Moreno; J M Hernández-Rivas; R Ayala; M J Calasanz; M J Larrayoz; L F Brichs; M Gonzalez-Vicent; D G Pisano; M A Piris; S Álvarez; J C Cigudosa
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

5.  Clinical and biologic features of CD4(+)CD56(+) malignancies.

Authors:  Jean Feuillard; Marie-Christine Jacob; Françoise Valensi; Marc Maynadié; Rémy Gressin; Laurence Chaperot; Christine Arnoulet; Françoise Brignole-Baudouin; Bernard Drénou; Eliane Duchayne; Annie Falkenrodt; Richard Garand; Emanuelle Homolle; Bernard Husson; Emilienne Kuhlein; Geneviève Le Calvez; Danielle Sainty; Marie-France Sotto; Franck Trimoreau; Marie-Christine Béné
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

Authors:  Dominique Leroux; Francine Mugneret; Mary Callanan; Isabelle Radford-Weiss; Nicole Dastugue; Jean Feuillard; Franseza Le Mée; Ghislaine Plessis; Pascaline Talmant; Nathalie Gachard; Françoise Uettwiller; Marie-Pierre Pages; Marie-Joëlle Mozziconacci; Virginie Eclache; Catherine Sibille; Hervé Avet-Loiseau; Marina Lafage-Pochitaloff
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 7.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Authors:  Michael J Rauh; Fazlur Rahman; David Good; Jeffrey Silverman; Michael K Brennan; Nikolay Dimov; Jane Liesveld; Daniel H Ryan; W Richard Burack; John M Bennett
Journal:  Leuk Res       Date:  2011-09-03       Impact factor: 3.156

8.  Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.

Authors:  Armin G Jegalian; Nataliya P Buxbaum; Fabio Facchetti; Mark Raffeld; Stefania Pittaluga; Alan S Wayne; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-07-27       Impact factor: 9.941

Review 9.  Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?

Authors:  Francine Garnache-Ottou; Jean Feuillard; Philippe Saas
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998

10.  Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

Authors:  Nikolaos J Tsagarakis; Nektaria A Kentrou; Konstantinos A Papadimitriou; Maria Pagoni; Garyfallia Kokkini; Helen Papadaki; Vassiliki Pappa; Theodoros Marinakis; Nikolaos I Anagnostopoulos; Chrissanthi Vadikolia; Achilleas Anagnostopoulos; Maria K Angelopoulou; Evangelos Terpos; Christos Poziopoulos; Konstantinos Anargyrou; Dimitra Rontogianni; Theodora Papadaki; Aikaterini Psarra; Flora N Kontopidou; Dimitra Skoumi; Stefanos I Papadhimitriou; Georgios Paterakis
Journal:  Leuk Res       Date:  2009-09-29       Impact factor: 3.156
View more
  1 in total

1.  Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.

Authors:  Xinmei Dang; Di Zhou; Lingjun Meng; Lintao Bi
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.